Luye Pharma Group Ltd. (OTCMKTS:LYPHF – Get Free Report) was the target of a large increase in short interest during the month of June. As of June 15th, there was short interest totaling 1,307,000 shares, an increase of 269.2% from the May 31st total of 354,000 shares. Based on an average daily volume of 527,273 shares, the short-interest ratio is currently 2.5 days.
Luye Pharma Group Price Performance
LYPHF remained flat at $0.20 during trading on Friday. The firm’s 50 day moving average is $0.30 and its 200 day moving average is $0.35. Luye Pharma Group has a fifty-two week low of $0.20 and a fifty-two week high of $0.33.
About Luye Pharma Group
Luye Pharma Group Ltd. is a China-based pharmaceutical company headquartered in Yantai, Shandong Province. Established in 1994, the company specializes in the research, development, manufacturing and marketing of a broad portfolio of medicaments and health-care products. Luye Pharma structures its operations across three main segments: innovative drugs, generic drugs and over-the-counter (OTC) health and wellness products. Through in-house R&D and strategic collaborations, the company aims to address unmet medical needs in both domestic and international markets.
The company’s product offerings encompass key therapeutic areas such as oncology, cardiovascular disease, gastroenterology and respiratory illnesses.
Recommended Stories
- Five stocks we like better than Luye Pharma Group
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
- 3 Overlooked Tech ETFs That Are Quietly Killing It This Year
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
Receive News & Ratings for Luye Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luye Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
